North American clinical management guidelines for hidradenitis suppurativa: A publication from the United States and Canadian Hidradenitis Suppurativa Foundations: Part II: Topical, intralesional, and systemic medical management

Ali Alikhan, Christopher Sayed, Afsaneh Alavi, Raed Alhusayen, Alain Brassard, Craig Burkhart, Karen Crowell, Daniel B. Eisen, Alice B. Gottlieb, Iltefat Hamzavi, Paul G. Hazen, Tara Jaleel, Alexa B. Kimball, Joslyn Sciacca Kirby, Michelle A. Lowes, Robert Micheletti, Angela Miller, Haley B. Naik, Dennis Orgill, Yves Poulin

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Hidradenitis suppurativa is a severe and debilitating dermatologic disease. Clinical management is challenging and consists of both medical and surgical approaches, which must often be combined for best outcomes. Therapeutic approaches have evolved rapidly in the last decade and include the use of topical therapies, systemic antibiotics, hormonal therapies, and a wide range of immunomodulating medications. An evidence-based guideline is presented to support health care practitioners as they select optimal medical management strategies and is reviewed in this second part of the management guidelines. A therapeutic algorithm informed by the evidence available at the time of the review is provided.

Original languageEnglish (US)
Pages (from-to)91-101
Number of pages11
JournalJournal of the American Academy of Dermatology
Volume81
Issue number1
DOIs
StatePublished - Jul 1 2019

Fingerprint

Hidradenitis Suppurativa
Publications
Guidelines
Therapeutics
Anti-Bacterial Agents
Delivery of Health Care

All Science Journal Classification (ASJC) codes

  • Dermatology

Cite this

Alikhan, Ali ; Sayed, Christopher ; Alavi, Afsaneh ; Alhusayen, Raed ; Brassard, Alain ; Burkhart, Craig ; Crowell, Karen ; Eisen, Daniel B. ; Gottlieb, Alice B. ; Hamzavi, Iltefat ; Hazen, Paul G. ; Jaleel, Tara ; Kimball, Alexa B. ; Sciacca Kirby, Joslyn ; Lowes, Michelle A. ; Micheletti, Robert ; Miller, Angela ; Naik, Haley B. ; Orgill, Dennis ; Poulin, Yves. / North American clinical management guidelines for hidradenitis suppurativa : A publication from the United States and Canadian Hidradenitis Suppurativa Foundations: Part II: Topical, intralesional, and systemic medical management. In: Journal of the American Academy of Dermatology. 2019 ; Vol. 81, No. 1. pp. 91-101.
@article{c3bda6d548a84f8b86fc153d7d800823,
title = "North American clinical management guidelines for hidradenitis suppurativa: A publication from the United States and Canadian Hidradenitis Suppurativa Foundations: Part II: Topical, intralesional, and systemic medical management",
abstract = "Hidradenitis suppurativa is a severe and debilitating dermatologic disease. Clinical management is challenging and consists of both medical and surgical approaches, which must often be combined for best outcomes. Therapeutic approaches have evolved rapidly in the last decade and include the use of topical therapies, systemic antibiotics, hormonal therapies, and a wide range of immunomodulating medications. An evidence-based guideline is presented to support health care practitioners as they select optimal medical management strategies and is reviewed in this second part of the management guidelines. A therapeutic algorithm informed by the evidence available at the time of the review is provided.",
author = "Ali Alikhan and Christopher Sayed and Afsaneh Alavi and Raed Alhusayen and Alain Brassard and Craig Burkhart and Karen Crowell and Eisen, {Daniel B.} and Gottlieb, {Alice B.} and Iltefat Hamzavi and Hazen, {Paul G.} and Tara Jaleel and Kimball, {Alexa B.} and {Sciacca Kirby}, Joslyn and Lowes, {Michelle A.} and Robert Micheletti and Angela Miller and Naik, {Haley B.} and Dennis Orgill and Yves Poulin",
year = "2019",
month = "7",
day = "1",
doi = "10.1016/j.jaad.2019.02.068",
language = "English (US)",
volume = "81",
pages = "91--101",
journal = "Journal of the American Academy of Dermatology",
issn = "0190-9622",
publisher = "Mosby Inc.",
number = "1",

}

Alikhan, A, Sayed, C, Alavi, A, Alhusayen, R, Brassard, A, Burkhart, C, Crowell, K, Eisen, DB, Gottlieb, AB, Hamzavi, I, Hazen, PG, Jaleel, T, Kimball, AB, Sciacca Kirby, J, Lowes, MA, Micheletti, R, Miller, A, Naik, HB, Orgill, D & Poulin, Y 2019, 'North American clinical management guidelines for hidradenitis suppurativa: A publication from the United States and Canadian Hidradenitis Suppurativa Foundations: Part II: Topical, intralesional, and systemic medical management', Journal of the American Academy of Dermatology, vol. 81, no. 1, pp. 91-101. https://doi.org/10.1016/j.jaad.2019.02.068

North American clinical management guidelines for hidradenitis suppurativa : A publication from the United States and Canadian Hidradenitis Suppurativa Foundations: Part II: Topical, intralesional, and systemic medical management. / Alikhan, Ali; Sayed, Christopher; Alavi, Afsaneh; Alhusayen, Raed; Brassard, Alain; Burkhart, Craig; Crowell, Karen; Eisen, Daniel B.; Gottlieb, Alice B.; Hamzavi, Iltefat; Hazen, Paul G.; Jaleel, Tara; Kimball, Alexa B.; Sciacca Kirby, Joslyn; Lowes, Michelle A.; Micheletti, Robert; Miller, Angela; Naik, Haley B.; Orgill, Dennis; Poulin, Yves.

In: Journal of the American Academy of Dermatology, Vol. 81, No. 1, 01.07.2019, p. 91-101.

Research output: Contribution to journalArticle

TY - JOUR

T1 - North American clinical management guidelines for hidradenitis suppurativa

T2 - A publication from the United States and Canadian Hidradenitis Suppurativa Foundations: Part II: Topical, intralesional, and systemic medical management

AU - Alikhan, Ali

AU - Sayed, Christopher

AU - Alavi, Afsaneh

AU - Alhusayen, Raed

AU - Brassard, Alain

AU - Burkhart, Craig

AU - Crowell, Karen

AU - Eisen, Daniel B.

AU - Gottlieb, Alice B.

AU - Hamzavi, Iltefat

AU - Hazen, Paul G.

AU - Jaleel, Tara

AU - Kimball, Alexa B.

AU - Sciacca Kirby, Joslyn

AU - Lowes, Michelle A.

AU - Micheletti, Robert

AU - Miller, Angela

AU - Naik, Haley B.

AU - Orgill, Dennis

AU - Poulin, Yves

PY - 2019/7/1

Y1 - 2019/7/1

N2 - Hidradenitis suppurativa is a severe and debilitating dermatologic disease. Clinical management is challenging and consists of both medical and surgical approaches, which must often be combined for best outcomes. Therapeutic approaches have evolved rapidly in the last decade and include the use of topical therapies, systemic antibiotics, hormonal therapies, and a wide range of immunomodulating medications. An evidence-based guideline is presented to support health care practitioners as they select optimal medical management strategies and is reviewed in this second part of the management guidelines. A therapeutic algorithm informed by the evidence available at the time of the review is provided.

AB - Hidradenitis suppurativa is a severe and debilitating dermatologic disease. Clinical management is challenging and consists of both medical and surgical approaches, which must often be combined for best outcomes. Therapeutic approaches have evolved rapidly in the last decade and include the use of topical therapies, systemic antibiotics, hormonal therapies, and a wide range of immunomodulating medications. An evidence-based guideline is presented to support health care practitioners as they select optimal medical management strategies and is reviewed in this second part of the management guidelines. A therapeutic algorithm informed by the evidence available at the time of the review is provided.

UR - http://www.scopus.com/inward/record.url?scp=85065249876&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85065249876&partnerID=8YFLogxK

U2 - 10.1016/j.jaad.2019.02.068

DO - 10.1016/j.jaad.2019.02.068

M3 - Article

C2 - 30872149

AN - SCOPUS:85065249876

VL - 81

SP - 91

EP - 101

JO - Journal of the American Academy of Dermatology

JF - Journal of the American Academy of Dermatology

SN - 0190-9622

IS - 1

ER -